Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-499-3 | CAS number: 26172-54-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity
This study was conducted to assess the acute toxicity of the test article, MIT.HCl, following a single oral administration to a small number of rats. The study design provides information for hazard assessment and classification and enables a chemical to be assigned to toxicity classes but severely restricts animal usage.
Individual female rats were dosed sequentially at the following dose levels until one of the stopping criteria (as defined in OECD 425) was met: 175, 550, 175, 550, 175 and 55 mg/kg bw. The test article was dispersed in purified water and administered at a dose volume of 10 mL/kg. Surviving animals were killed on Day 15 and all animals subsequently underwent a full necropsy.
Both animals dosed at 550 mg/kg bw were killedin extremiswithin 1 to 4 hours of dosing. One animal dosed at 175 mg/kg bw was found dead on Day 2.
Principal signs of reaction to treatment were piloerection and dyspnoea. Less common signs were hunched posture, ataxia, hypothermia and tonic convulsions. These signs developed immediately after dosing and lasted up to 4 hours post dosing.
All surviving rats achieved body weight gains during the first and second weeks of the study.
No macroscopic changes were noted at necropsy, except for pale lungs, red and thick fundus region of the stomach, gelatinous appearance of the mucosal surface of the fundus region of the stomach and small caecum which were noted in the animal dosed at 550 mg/kg bw that was killed in extremis 4 hours after dosing. These macrosocpic changes are commonly observed following the oral administration of an unpalatable or slightly irritant test article, with regurgitation and aspiration into pulmonary system and in isolated are considered not to associated with systemic toxicity.
Under the conditions of this study the rat acute oral LD50 was 175 mg/kg bw in female rats. Therefore, according to Annex I for Regulation (EC) 1272/2008 MIT.HCl must be classified in Category 3. The signal word "Danger" and hazard statement H301 "Toxic if swallowed" is required.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 August 2017 to 3 October 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- up-and-down procedure
- Limit test:
- no
- Specific details on test material used for the study:
- - Identification: MIT.HCl (Methyl isothiazolinone hydrochloric acid)
- CAS no.: 26172-54-3
- Source and lot/batch No.of test material: Sigma-Aldrich / 10013913
- Expiration date of the lot/batch: 30 Nov 2018
- Purity test date: 23 Nov 2016
- Purity: >99.9%
- Apperance: White to light beige powder
- Moelcular weight: 151.61 g/mol
- Storage condition of test material: 2 to 8°C, protected from light - Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate
- Females nulliparous and non-pregnant: Yes
- Age at study initiation: 8 to 11 weeks
- Weight at study initiation: 178 to 197 g
- Fasting period before study: evening before dosing
- Housing: groups of up to five during the acclimatisation period. From the day prior to dosing (Day-1), each rat was individually housed in a similar cage
- Diet: ad libitum to 5LF2 EU Rodent Diet 14% except for a period of fasting from the evening of the day prior to dosing (Day-1) until approximately 3 hours after dosing
- Water: Municipal water, ad libitum
- Acclimation period: 8 to 27 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 45-65%
- Air changes (per hr): 15-20 air changes/h
- Photoperiod (hrs dark / hrs light): 12 hours light/dark
IN-LIFE DATES: From: 22 August 2017 to 3 October 2017 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Doses were administered orally, by gavage, using plastic syringes and rubber catheters employing a dose volume of 10 mL/kg bw. Each rat was dosed once on Day 1, by passing the tip of a catheter along the oesophagus and instilling the test article into the gastric lumen.
- Doses:
- 55, 175, 550 mg/kg bw
- No. of animals per sex per dose:
- 55mg/kg bw: 1 animal
175 mg/kg bw: 3 animals
550 mg/kg bw: 2 animals
2000 mg/kg bw: 3 animals - Control animals:
- no
- Details on study design:
- One animal was dosed first at a dose of 175 mg/kg bw. As the animal survived, the dose for the next animal was increased to 550 mg/kg bw based on a dose progression factor of 3.2, based on the recommendations of OECD 425. This stepped nature of the OECD 425 design provides for the first few doses to function as a self-adjusting sequence.
- Statistics:
- The median lethal dose level was determined by the maximum likelihood method using the Acute Oral Toxicity (OECD Test Guideline 425) Statistical Programme (AOT 425 StatPgm) version 1.0, 2001
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- ca. 175 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Both animals dosed at 550 mg/kg bw were killed in extremis within 1 to 4 hours of dosing. One animal dosed at 175 mg/kg bw was found dead on Day 2.
Two of three animals dosed at 175 mg/kg bw and the animal dosed at 55 mg/kg bw survived. - Clinical signs:
- other: No clinical signs were noted in the animal dosed at 55 mg/kg bw and in one animal dosed at 175 mg/kg bw. Clinical signs noted in the other two animals dosed at 175 mg/kg bw were piloerection, decreased activity, hunched posture and ataxia. The clinical si
- Gross pathology:
- Macroscopic changes noted at necropsy included pale lungs, red and thick fundus region of the stomach, gelatinous appearance of the mucosal surface of the fundus region of the stomach and small caecum which were limited to the animal dosed at 550 mg/kg bw that was killed in extremis 4 hours after dosing. These macroscopic changes are commonly observed following the oral administration of an unpalatable or slightly irritant test article, with regurgitation and aspiration into pulmonary system and in isolated are considered not to associated with systemic toxicity.
- Other findings:
- n/a
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- Under the conditions of this study the rat acute oral LD50 was 175 mg/kg bw in female rats. Therefore, according to Annex I for Regulation (EC) 1272/2008 MIT.HCl must be classified in Category 3. The signal word "Danger" and hazard statement H301 "Toxic if swallowed" are required.
- Executive summary:
This study was conducted to assess the acute toxicity of the test article, MIT.HCl, following a single oral administration to a small number of rats. The study design provides information for hazard assessment and classification and enables a chemical to be assigned to toxicity classes but severely restricts animal usage.
Individual female rats were dosed sequentially at the following dose levels until one of the stopping criteria (as defined in OECD 425) was met: 175, 550, 175, 550, 175 and 55 mg/kg bw. The test article was dispersed in purified water and administered at a dose volume of 10 mL/kg. Surviving animals were killed on Day 15 and all animals subsequently underwent a full necropsy.
Both animals dosed at 550 mg/kg bw were killedin extremiswithin 1 to 4 hours of dosing. One animal dosed at 175 mg/kg bw was found dead on Day 2.
Principal signs of reaction to treatment were piloerection and dyspnoea. Less common signs were hunched posture, ataxia, hypothermia and tonic convulsions. These signs developed immediately after dosing and lasted up to 4 hours post dosing.
All surviving rats achieved body weight gains during the first and second weeks of the study.
No macroscopic changes were noted at necropsy, except for pale lungs, red and thick fundus region of the stomach, gelatinous appearance of the mucosal surface of the fundus region of the stomach and small caecum which were noted in the animal dosed at 550 mg/kg bw that was killedin extremis4 hours after dosing. These macrosocpic changes are commonly observed following the oral administration of an unpalatable or slightly irritant test article, with regurgitation and aspiration into pulmonary system and in isolated are considered not to associated with systemic toxicity.
Under the conditions of this study the rat acute oral LD50 was 175 mg/kg bw in female rats. Therefore, according to Annex I for Regulation (EC) 1272/2008 MIT.HCl must be classified in Category 3. The signal word "Danger" and hazard statement H301 "Toxic if swallowed" are required.
Reference
Table: 7.2.1/01-1: Results of acute oral toxicity study in rats dosed with MIT.HCl
Dose |
Toxicological results * |
Duration of signs |
Time of death |
LD50(mg/kg bw) |
55 |
0/1/1 |
n/a |
n/a |
175 mg/kg bw |
175 |
1/2/3 |
Piloerection: 4 h Dyspnoea: 3 h Hunched posture: 3 h Ataxia: 2 h |
Day 2 |
|
550 |
2/2/2 |
Piloerection: 6 h Dyspnoea: 4 h Prone posture / hypothermia / ptosis / tonic convulsion: immediately prior to death |
1 h and 6.5 h post dosing |
* Number of animals which died/number of animals with clinical signs/number of animals used
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 175 mg/kg bw
- Quality of whole database:
- Klimisch 1
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Comparison with the CLP criteria
The acute oral LD50 in the rat of 175 mg/kg bw triggers classification according to Annex I for Regulation (EC) 1272/2008 MIT.HCl and must be classified in Category 3. The signal word "Danger" and hazard statement H301 "Toxic if swallowed" is required
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.